Microvascular complications of type 2 diabetes with or without MASLD: the EPSOMIP study, a primary care cohort study.

ABSTRACT:

Background

Previous studies have shown inconsistent results for the microvascular complication risk in patients with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD). In addition, many of these studies have been done in specialist care setting. We therefore aimed to explore the association between MASLD and chronic kidney disease, retinopathy, neuropathy, and diabetic foot ulcers in a primary care setting.

Methods

Participants with type 2 diabetes were recruited in primary care. Hepatic triglyceride content was assessed using magnetic resonance imaging with liver proton density fat fraction (MASLD ≥ 5%) or vibration-controlled transient elastography with controlled attenuation parameter (MASLD ≥ 248 dB/m), and hepatic fibrosis was assessed

SUBMITTER: Bergram M 

PROVIDER: S-EPMC12604417 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature